KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Gross Profit (2016 - 2025)

Bausch Health Companies' Gross Profit history spans 17 years, with the latest figure at $2.9 billion for Q4 2025.

  • For Q4 2025, Gross Profit rose 1.62% year-over-year to $2.9 billion; the TTM value through Dec 2025 reached $10.3 billion, up 10.61%, while the annual FY2025 figure was $10.3 billion, 6.65% up from the prior year.
  • Gross Profit for Q4 2025 was $2.9 billion at Bausch Health Companies, up from $2.7 billion in the prior quarter.
  • Across five years, Gross Profit topped out at $4.9 billion in Q4 2021 and bottomed at $1.4 billion in Q1 2023.
  • The 5-year median for Gross Profit is $2.1 billion (2021), against an average of $2.4 billion.
  • The largest annual shift saw Gross Profit surged 9732.0% in 2021 before it plummeted 55.49% in 2022.
  • A 5-year view of Gross Profit shows it stood at $4.9 billion in 2021, then tumbled by 55.49% to $2.2 billion in 2022, then surged by 93.42% to $4.2 billion in 2023, then crashed by 31.64% to $2.9 billion in 2024, then rose by 1.62% to $2.9 billion in 2025.
  • Per Business Quant, the three most recent readings for BHC's Gross Profit are $2.9 billion (Q4 2025), $2.7 billion (Q3 2025), and $2.5 billion (Q2 2025).